Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Purpose of Investigation: To determine the endometrial thickness (ET) threshold to predict high risk of endometrial cancer (EC) in symptomatic and asymptomatic postmenopausal patients. It is also assessed whether additional ultrasonic findings (vascularisation, myometrial invasion, and inhomogeneity) improves diagnostic accuracy. Materials and Methods: In a prospective study the authors included 447 postmenopausal patients, treated for endometrial pathology. Ultrasound assessment was followed by endometrial sampling and histopathological examination. Results were compared according to presence of symptoms and histopathological findings (benign and malignant). Results: Eighty-six percent (385) patients were symptomatic and 14% (62) were asymptomatic. In the symptomatic patients with ET ≥ 5 mm, 17.5% had EC (CI: 13.5 -22); there was no patient with EC and ET less than 5 mm (CI: 0-15). All asymptomatic patients with ET ≥ 11 mm had benign findings. Three asymptomatic patients with malignancy were discovered because of other suspicious findings than ultrasound. Additional ultrasonic assessment showed statistically relevant results in symptomatic group (p < 0.05). Conclusions: In symptomatic women, less than 5 mm ET threshold rules out patients with EC with good certainty. In asymptomatic patients, ET measurement played no role in discovering EC.
Authors and Affiliations
K. Jakopič Maček, Š. Bricl, I. Verdenik, B. Kobal
Keywords
Related Articles
- EP ID EP663027
- DOI 10.12892/ejgo4256.2019
- Views 81
- Downloads 0
Resource utilisation and cost of cervical cancer and dysplasia in Croatia
Purpose of investigation: To analyse resource utilisation and costs due to cervical cancer and dysplasia in Croatia. Materials and Methods: Patients diagnosed with cervical cancer were identified from the Croatian Nation...
The differential gene expression of Notch receptors in primary and metastatic epithelial ovarian cancer sites
Purpose of Investigation: Notch signaling belongs among the candidate pathways for targeted therapies in ovarian cancer. While Notch 3 and Notch 1 overexpression has already been confirmed in ovarian carcinomas compared...
The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro
Purpose of investigation: The pleiotropic factor Y-box binding protein-1 (YB-1) is clinically correlated with breast cancer patients’ poor outcome. Due to the intereference of YB-1 with the estrogen receptor, the authors...
Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer
Objective: Perioperative intraperitoneal chemotherapy after cytoreductive surgery is used in ovarian cancer treatment. The purpose of the study is the evaluation of the effect of hyperthermic intraoperative intraperitone...
High immunoexpression of progesterone-induced blocking factor (PIBF) in endometrial cancer
Purpose of Investigation: This study aims to investigate PIBF expression levels in normal, hyperplastic, and endometrioid adenocarcinoma paraffin blocks. The purpose of this study is to determine the PIBF expression leve...